Diabetes after Removal of Insulin Tumours of Pancreas: A Long-term Follow-up Survey of 11 Patients

Dunn, D. C.
April 1971
British Medical Journal;4/10/1971, Vol. 2 Issue 5753, p84
Academic Journal
No abstract available.


Related Articles

  • HPB Surgery: Mayo Clinic: Diabetes can be controlled in patients after pancreas removal.  // Biomedical Market Newsletter;8/28/2012, Vol. 21, p1 

    The article informs that pancreatic cancer patients can manage diabetes after the complete removal of pancreas.

  • Management of Graft Duodenal Leak in Simultaneous Pancreas Kidney Transplant-a Case Report from India and Review of Literature. Kumar, Sunil; Singh, Sarbpreet; Kenwar, Deepesh; Rathi, Manish; Bhadada, Sanjay; Sharma, Ashish; Gupta, Vikas; Bhansali, Anil; Lal, Anupam; Minz, Mukut // Indian Journal of Surgery;Oct2016, Vol. 78 Issue 5, p402 

    Pancreatic transplantation is currently the only effective cure for Type 1 diabetes mellitus. It allows long-term glycemic control without exogenous insulin and amelioration of secondary diabetic complications. In India, pancreas transplant has not yet established with only a single successful...

  • Total Pancreatectomy for the Treatment of Chronic Pancreatitis: Indications, Outcomes, and Recommendations. Behrman, Stephen W.; Mulloy, Matthew // American Surgeon;Apr2006, Vol. 72 Issue 4, p297 

    Total pancreatectomy (TP) for chronic pancreatitis (CP) has not gained widespread acceptance because of concerns regarding technical complexity, diabetic complications, and uncertainty with respect to long-term pain relief. Records of patients having TP from 1997 to 2005 were reviewed, Patient...

  • Retrospective Assessment of Islet Cell Autoantibodies in Pancreas Organ Donors. Diamantopoulos, Stavros; Allende, Gloria; Ferreira, Joseph M.; Ciancio, Gaetano; Burke, George W.; Pugliese, Alberto // Diabetes Care;Sep2008, Vol. 31 Issue 9, p1741 

    OBJECTIVE -- Of deceased pancreas donors, 3-4% may have autoantibodies (AAb) to pancreatic islet cell antigens; these autoantibodies are well-established markers of type 1 diabetes. We investigated whether donor AAb positivity could affect the outcome of pancreas transplantation. RESEARCH DESIGN...

  • Pancreas organ transplantation: Short and long-term results in terms of diabetes control. Hopt, Ulrich Theodor; Drognitz, Oliver // Langenbeck's Archives of Surgery;Oct2000, Vol. 385 Issue 6, p379 

    Diabetes mellitus is a very common and dreadful disease which cannot be cured by exogenous insulin substitution. Many of the patients suffer from recurrent, and sometimes rather dangerous, hypo- or hyperglycemias and, in the long term, from the well-known secondary diabetic complications. At the...

  • Selecting IDDM patients likely to benefit from pancreas transplantation. Dale, David C.; Federman, Daniel D. // Cortlandt Forum;01/25/98, Vol. 11 Issue 1, p19 

    Looks at the factors that needs to be considered in evaluating insulin dependent diabetes mellitus (IDDM) patients who are likely to benefit from pancreas transplantation. Postoperative complications and new for long-term immunosuppression in patients who undergo pancreas transplantation.

  • pancreatectomy. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p584 

    An encyclopedia entry for "pancreatectomy" is presented. It refers to the surgical removal of all or part of the pancreas to treat pancreatitis. The procedure is sometimes used in treating insulinomas or insulin-producing tumours. A possible complication of pancreatectomy is the development of a...

  • Vascularised pancreas transplantation. Stratta, R.J. // BMJ: British Medical Journal (International Edition);9/21/96, Vol. 313 Issue 7059, p703 

    Discusses pancreas transplantation as a treatment for insulin-dependent diabetes mellitus. Controversy on the use of pancreas transplantation; Prognosis for patients with pancreas transplants; Potentials in relieving secondary complications of diabetes; Advantages and disadvantages.

  • Normoglycemia and preserved insulin secretory reserve in diabetic patients 10-18 years after pancreas transplantation. Robertson, R. Paul; Sutherland, David E.R.; Lanz, Karla J.; Robertson, R P; Sutherland, D E; Lanz, K J // Diabetes;Sep99, Vol. 48 Issue 9, p1737 

    Pancreas transplantation is a controversial form of therapy for type I diabetes. A major obstacle to acceptance of this procedure for many physicians is the lack of demonstrable long-term success. We performed these studies to assess the hypothesis that successful pancreas transplantation is...

  • Diabetes mellitus and its impact on long-term outcomes after coronary artery bypass graft surgery. Wit, M.; Mulder, M.; Jansen, E.; Umans, V. // Acta Diabetologica;Apr2013, Vol. 50 Issue 2, p123 

    Diabetes mellitus (DM) is an important risk factor for accelerated atherosclerosis and increases cardiovascular disease. Several studies found a higher mortality rate in postoperative diabetic patients than in non-diabetic patients. However, other studies found conflicting evidence on bypass...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics